* Please refer to the English Version as our Official Version.
Qorvo®, Inc. announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Qorvo's Omnia™ SARS-CoV-2 antigen test, making it available for use in the Field care (POC) setting.
